Hélène Bénédetti
8
Documents
Publications
- 8
- 8
- 8
- 7
- 7
- 5
- 4
- 4
- 4
- 4
- 4
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
Design, Synthesis and SAR in 2,4,7-Trisubstituted Pyrido[3,2-d]Pyrimidine Series as Novel PI3K/mTOR InhibitorsMolecules, 2021, 26 (17), pp.5349. ⟨10.3390/molecules26175349⟩
Article dans une revue
hal-03348966v1
|
Développement de petites molécules inhibitrices des LIM kinases, nouvelles cibles thérapeutiques pour lutter contre le cancer, les maladies neurologiques et la neurofibromatoseJournée Fédération CBM-ICOA, Jan 2018, Orléans, France
Communication dans un congrès
hal-02928530v1
|
|
Neurofibromatosis type I: from basic to applied research4th LIA Workshop, Jun 2017, Cracovie, Poland
Communication dans un congrès
hal-02928517v1
|
Development of small molecule inhibitors of LIM kinases, new therapeutic targets to treat Neurofibromatosis type IJoint Global Neurofibromatosis Conference 2018, Nov 2018, Paris, France
Poster de conférence
hal-02924077v1
|
|
LIM Kinases: new anticancer therapeutic targetsBreast Cancer Symposium, Jun 2017, Nantes, France
Poster de conférence
hal-03680148v1
|
|
LIM kinases: new therapeutic targets to treat Neurofibromatosis type IPoster de conférence hal-02453490v1 |
|
Projet Région LiCorNe: LIMK protein inhibitors, new therapeutic agents for treatment of cognitive disorders associated with type I NeurofibromatosisJournée Fédération PCV FR2708, Jan 2016, Orléans, France
Poster de conférence
hal-02924056v1
|
4-(7H-Pyrrolo[2,3-D]pyrimidin-4-yl)-3,6-dihydropyridine-(2H)-carboxamide derivatives as Limk and/or Rock kinases inhibitors for use in the treatment of cancerFrance, Patent n° : WO2021239727 A1. BCT. 2021
Brevet
hal-03555349v1
|